The 48th Annual ICAAC/IDSA 46th Annual Meeting (ICAAC/IDSA 2008)

TheBody.com covers the 48th Annual ICAAC/IDSA 46th Annual Meeting; Washington, D.C.; October 25-28, 2008

BROWSE ICAAC/IDSA 2008 COVERAGE

Conference Highlights: Which Studies Are Most Likely to Change the Lives of People With HIV?
Joel Gallant, M.D., one of the United States' foremost HIV experts, walks us through some of the most important findings presented at ICAAC/IDSA 2008.

Read or listen (27 min.):

More Top Stories:

Starting HAART: Should 500 Become the New 350?

Mari Kitahata, M.D., and Daniel Kuritzkes, M.D., discuss a 5,926-patient trial that found a 74% higher mortality risk among those who deferred HAART until their CD4 dropped below 350 rather than initiating when their CD4 was between 351 and 500. Dr. Kuritzkes also touches on new developments in HIV drug resistance.

Read or listen (35 min.):

More Highlights:

Continuous HAART Associated With Decreased Bone Mineral Density, SMART Substudy Finds

In one of ICAAC/IDSA 2008's most talked-about studies, a SMART substudy suggests that participants who remained on HAART continuously experienced a significantly greater reduction in bone marrow density than patients on intermittent therapy. (An interview with Birgit Grund, Ph.D.)

Read or listen (7 min.):

More Highlights:

About This Conference

The Body's coverage of the 48th Annual ICAAC/IDSA 46th Annual Meeting (ICAAC/IDSA 2008) will include a wide array of individual presentations and symposia, as well as summaries of some of the hottest topics in HIV research.

For more information on ICAAC/IDSA 2008, please visit the conference's Web site. You may also view the conference program planner online.

Funding for coverage of this conference is provided, in part, by Abbott Laboratories.

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.